Clinical trials
Completed Lung Neoplasms trials in Mexico
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 3 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 3 |
| 2020 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Instituto Nacional de Cancerologia de Mexico | 5 |
| AstraZeneca | 2 |
| Bristol-Myers Squibb | 2 |
| Genzyme, a Sanofi Company | 2 |
| Novartis Pharmaceuticals | 2 |
| Eli Lilly and Company | 1 |
| Genentech, Inc. | 1 |
| Incyte Corporation | 1 |
| Latin American Cooperative Oncology Group | 1 |
| Merck KGaA, Darmstadt, Germany | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 20 |
| Carcinoma, Non-Small-Cell Lung | 12 |
| Neoplasm Metastasis | 3 |
| Small Cell Lung Carcinoma | 3 |
| Adenocarcinoma of Lung | 2 |
| Brain Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Breast Neoplasms, Male | 1 |
| Dysgeusia | 1 |
| Exanthema | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.